Dj. Ciavatta et al., MOUSE MODEL OF HUMAN BETA(0) THALASSEMIA - TARGETED DELETION OF THE MOUSE BETA(MAJ)-GLOBIN AND BETA(MIN)-GLOBIN GENES IN EMBRYONIC STEM CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(20), 1995, pp. 9259-9263
beta(0)-Thalassemia is an inherited disorder characterized by the abse
nce of beta-globin polypeptides derived from the affected allele, The
molecular basis for this deficiency is a mutation of the adult beta-gl
obin structural gene or cis regulatory elements that control beta-glob
in gene expression. A mouse model of this disease would enable the tes
ting of therapeutic regimens designed to correct the defect, Here we r
eport a 16-kb deletion that includes both adult beta-like globin genes
, beta(maj) and beta(maj), in mouse embryonic stem cells. Heterozygous
animals derived from the targeted cells are severely anemic with dram
atically reduced hemoglobin levels, abnormal red cell morphology, sple
nomegaly, and markedly increased reticulocyte counts, Homozygous anima
ls die in utero; however, heterozygous mice are fertile and transmit t
he deleted allele to progeny, The anemic phenotype is completely rescu
ed in progeny derived from mating beta(0)-thalassemic animals with tra
nsgenic mice expressing high levels of human hemoglobin A, The beta(0)
-thalassemic mice can be used to test genetic therapies for beta(0)-th
alassemia and can be bred with transgenic mice expressing high levels
of human hemoglobin HbS to produce an improved mouse model of sickle c
ell disease.